Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pivotal study of Rituximab in relapsed low-grade or follicular lymphoma
NCT00168740Phase 3Completed
- Sponsor
- Biogen
- Start
- Apr 1995
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of rituximab in follicular lymphoma (FL), B cell lymphoma, sponsored by Biogen. Started Apr 1995; status: completed.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)B cell lymphoma
Beyond the preview
Go deeper on NCT00168740.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00168740.